APO-CARBAMAZEPINE CR 200 MG
CARBAMAZEPINE : 200 MG · DIN 02242908 · APOTEX INC
Health Canada status: APPROVED
What is APO-CARBAMAZEPINE CR?
APO-CARBAMAZEPINE CR 200 MG contains CARBAMAZEPINE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02242908, held by APOTEX INC, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as approved, status dated 18-Nov-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02242908 |
|---|---|
| Brand name | APO-CARBAMAZEPINE CR |
| Generic / active ingredient | CARBAMAZEPINE : 200 MG |
| Manufacturer | APOTEX INC |
| Strength | 200 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N03AF01 CARBAMAZEPINE |
| AHFS class | 28:12.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 18-Nov-2013 |
What can be used instead?
Other Canadian products sharing ATC code N03AF01 CARBAMAZEPINE. 11 of 46 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MINT-CARBAMAZEPINE | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02541238 |
| SANDOZ-CARBAMAZEPINE CR | 200 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02261839 |
| SANDOZ-CARBAMAZEPINE CR | 400 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02261847 |
| TARO-CARBAMAZEPINE | 100 MG / 5 ML | SUSPENSION | TARO PHARMACEUTICALS INC | MARKETED | DIN 02367394 |
| TARO-CARBAMAZEPINE CHEWABLE TABLETS | 100 MG | TABLET (CHEWABLE) | TARO PHARMACEUTICALS INC | MARKETED | DIN 02244403 |
| TARO-CARBAMAZEPINE CHEWABLE TABLETS | 200 MG | TABLET (CHEWABLE) | TARO PHARMACEUTICALS INC | MARKETED | DIN 02244404 |
| TEGRETOL | 200 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 00010405 |
| TEGRETOL CR | 200 MG | TABLET (EXTENDED-RELEASE) | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 00773611 |
| TEGRETOL CR | 400 MG | TABLET (EXTENDED-RELEASE) | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 00755583 |
| TEGRETOL SUSPENSION | 100 MG / 5 ML | SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 02194333 |
Who else supplies CARBAMAZEPINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CARBAMAZEPINE appears in 123 registered pack listings across 12 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.